StockTipsArenaBeta

BUY Mankind Pharma Limited — ICICI Securities

BUYMankind Pharma Limited

byICICI SecuritiesHorizon: NA (inferred Swing (≤2wk))6 Jul 2026via Economic Times New Stock Recos

Entry₹2,535Inferred
Target₹2,655
Total upside +4.73% (call closed)
Stop lossNot given
At expiry₹2,480.817 Jul 2026, 3:30 pm
Expired-2.14%
Follow ICICI Securities for new calls(19% target hit, 16 closed calls)Get alertsWatch MANKIND for new buy/sell callsGet alertsSee 1 active Swing call on MANKINDSee 185 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 17 Jul 2026
1 supporting1 neutral0 opposing
Supports the BUY call (1)

5 advisors have active short-term BUY calls on this stock, with 4 issued in the last 14 days

Advisor consensus · adjacent horizon·9 Jul · 1w ago

Neutral / worth noting (1)

Mankind Pharma Ltd's Board approved the incorporation of a wholly owned subsidiary in the Netherlands.

BSE · Company Update·11 Jul · 6d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.